Jeff Nelson says:
A number of readers sent me a recent video from the Viva Longevity channel.
In it, Chris describes a dramatic transformation in his blood work:
His conclusion is that adding nuts, oils, and higher-fat plant foods played a major role in the improvement.
But as I watched the video, one question kept nagging at me:
What role did his daily 40 mg dose of atorvastatin play?
Atorvastatin is a powerful cholesterol-lowering drug that can reduce LDL by 40–50% or more. Yet the video never shows us the blood work from the period when he was taking the statin while still following an Esselstyn-style diet.
Without those numbers, can we really know what caused what?
In today’s video, I walk through Chris’s timeline, his blood work, the published evidence on nuts and plant fats, and why I believe the most important question remains unanswered.
I’m not criticizing Chris’s results. I’m questioning the conclusion.
Dr. Esselstyn’s Results Showing over 99% effectiveness of his diet:
https://dresselstyn.com/JFP_06307_Article1.pdf
*************
Chris typed a comment/reply:
Thanks, Jeff. That’s a very reasonable thing to ask. But I thought it was pretty clear that I said statins only got me so far and didn’t move my triglycerides much (they aren’t effective for triglycerides), and that the dietary change did the rest. And note that Dr. Esselstyn was always very emphatic about no nuts and no oils. The point about an anecdote of 1 is spot on, but that’s why I went to so much effort to quote the truly big, long-term studies involving 100s of thousands of participants over decades; I even went to the home of the most cited scientist in the world who oversaw several of those studies. I just think Dr. Esselstyn is a really good guy who has helped a lot of patients, but the studies on nuts & seeds were not available to him when he formed his ideas.
Jeff Replied:
Chris, thanks for taking the time to respond. I appreciate it.
I agree that your personal experience is ultimately an anecdote of one. That’s why I’d genuinely be interested in seeing the timeline laid out in detail: blood tests, dates, medication changes, dietary changes, and anything else that changed along the way. The more transparent the timeline, the easier it is for everyone to understand what likely contributed to the results.
Where I think we may differ is on a broader question.
You place a great deal of emphasis on nutritional epidemiology and large observational studies. That’s a legitimate body of evidence, and obviously people like Walter Willett have contributed enormously to that literature.
But the tradition I come from in the plant-based movement was built largely by clinicians.
Kempner.
Morrison.
Pritikin.
Ornish.
Esselstyn.
McDougall.
These were doctors who spent decades treating sick patients and documenting outcomes.
They weren’t primarily asking, “Which foods are associated with the best outcomes in population studies?”
They were asking, “What happens when a patient with serious disease follows this program?”
Those are very different questions.
When Esselstyn looked at coronary disease, he wasn’t studying food-frequency questionnaires. He was following people with established disease and watching what happened to them over decades.
To me, that distinction matters.
The larger point isn’t really about your cholesterol results. It’s about how we evaluate evidence.
Should the plant-based movement primarily be guided by observational nutrition studies?
Or should it primarily be guided by the clinicians who spent decades trying and succeeding to reverse disease in actual patients?